Response Pharmaceuticals, Inc., a clinical-stage company focused on weight management and metabolic health in high-risk populations, today announced the early completion of enrollment in a Phase 2 ...

Shapiro failed to come through on a similar pledge to support transit during last year’s budget negotiations. The governor, ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

How do you compete with the best thing you've ever made? That's a question the artists had to ask themselves after these powerful albums.

Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.

Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price ...

The authors write "One of the most vexing hurdles plaintiffs must surmount in cases against municipalities for dangerous ...

When Lilly reported strong results from SURMOUNT-1 earlier this year, the drugmaker suggested it may be able to file for approval of tirzepatide in obesity before the end of this year. That won't ...

President Bola Tinubu has stressed the commitment of his administration to winning the war against insecurity in the country. The President gave this commitment, on Monday, at the Regimental ...